Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2802)	6/4/2010 12:28:18 PM
From: Jibacoa	Respond to of 3722

SURG is up 4.42% on moderate volume. The stock hasn't closed its UG of Apr28 and has resistance at the $2.80 & $3 level before it can retest its Apr28 H at $3.19 bigcharts.marketwatch.com But 4.42% in a day isn't bad. As I mentioned many times, one should be more than satisfied if one could average 2% on a week, and believe me, a net 2% on a month time isn't that easy. And that is because we all make mistakes along the way, And that's why is always very, very important to keep your losses short. <g> SURG has announced its preliminary results for the 3rdQ related to the allocation of proceeds from the settlement, license and supply agreement with ACL and the expected gain from the sale of the Omni product line to SYK. SURG has modest LTD and small +CF.The earnings on the 2ndQ were much better in spite of 5% lower revenues. There is no ACTAY The stock is off from its longer term DT coming from its March 2006 H at $8.78 With some good news it seems the stock could get to test the resistance at the $4 level.<g> bigcharts.marketwatch.com Bernard